Tandem Diabetes Care, Inc. Announces Executive Appointments
December 02, 2021 at 04:05 pm EST
Share
Tandem Diabetes Care, Inc. announced the appointments of Rick Carpenter as Chief Technical Officer, Libba Sapitsky as Senior Vice President, Customer Care, and Rizwan Pervez as Senior Vice President, Quality and Regulatory. Mr. Carpenter brings more than 30 years of engineering technology leadership experience. He most recently served as Senior Vice President of Engineering at Inseego Corporation, where he led the worldwide engineering team and was responsible for device hardware and software, cloud software, quality assurance, regulatory and product certification and technical account management. Ms. Sapitsky brings more than 30 years of experience in global life sciences and consumer care. She most recently served as Vice President of Customer Service and Operations at CVS Health, where she was a leader of contact center operations, customer experience, client support, continuous improvement and work force management teams. Mr. Pervez brings more than 20 years of leadership experience in Quality, Regulatory and Compliance spanning the diagnostics, point of care, in vitro diagnostics, software as a medical device, ventilation, ultrasound, surgical and interventional markets. He most recently served as Global Head of Quality and Regulatory Compliance for the Medtronic Respiratory Intervention business, where he had executive responsibility for establishing worldwide strategy and direction for quality and regulatory matters.
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.